This observational study examined the long-term effects of alpha-lipoic acid (ALA) supplementation in Alzheimer's disease (AD) patients over 48 months. Participants received 600 mg of ALA daily, which appeared to slow cognitive decline compared to the typical progression of AD, as measured by the Mini-Mental State Examination (MMSE). ALA’s antioxidant
